Lipoprotein apheresis: an established therapeutic modality for homozygous familial hypercholesterole...
Lipoprotein apheresis: an established therapeutic modality for homozygous familial hypercholesterolemia patients refractory to PCSK9 inhibitors: a case report and literature review
About this item
Full title
Author / Creator
Guan, Mingjing , Wang, Hao , Wang, Fang , Liang, Shichu , Ling, Li , Wang, Bo and Zhang, Ling
Publisher
England: BioMed Central
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central
Subjects
More information
Scope and Contents
Contents
Homozygous familial hypercholesterolemia (HoFH), is a rare genetic disorder characterized by dual mutations in the low-density lipoprotein receptor (LDLR) gene, leading to dysfunctional or absent LDLRs, often accompanied by severe premature Atherosclerotic Cardiovascular Disease (ASCVD) and exhibiting refractoriness to aggressive pharmacological in...
Alternative Titles
Full title
Lipoprotein apheresis: an established therapeutic modality for homozygous familial hypercholesterolemia patients refractory to PCSK9 inhibitors: a case report and literature review
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_8882f85639154d0a88e3c09c9586bbd7
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8882f85639154d0a88e3c09c9586bbd7
Other Identifiers
ISSN
1477-9560
E-ISSN
1477-9560
DOI
10.1186/s12959-024-00657-w
